Drugs / TMV-018
last change Nov 2020 re-read 2 minutes ago

TMV-018

Developed for
digestive system cancer
Investigated by
Assign Data Management and Biostatistics GmbH · Optimapharm · Themis Bioscience GmbH

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04195373 Nov 2020 digestive system cancer Themis Bioscience GmbH Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TMV-018 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04195373
Route Other “intra-tumoral TMV-018” NCT04195373